World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
76
Citations
18380
World Ranking
1842
National Ranking
65

Egbert Bakker publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Egbert Bakker sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 255 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Egbert Bakker D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Egbert Bakker sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 76 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • 1999 - Royal Netherlands Academy of Arts and Sciences

Overview

Egbert Bakker is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily spans the field of Medicine with a focused engagement in Psychiatry and Mental Health, Genetics, Biological Psychiatry, Reproductive Medicine, and Philosophy at a subfield level.

Their work covers multiple topics related to mental health and genetics, including schizophrenia research and treatment, bipolar disorder and treatment, tryptophan and brain disorders, BRCA gene mutations in cancer, ovarian cancer diagnosis and treatment, genomic variations and chromosomal abnormalities, and broader mental health and psychiatry issues.

Egbert Bakker has contributed to several publications across diverse scientific venues. Notable frequent publication venues include:

  • Schizophrenia Research
  • PubMed
  • The Lancet Psychiatry
  • CNS Spectrums
  • Harvard Dataverse

Several papers illustrate their recent research contributions:

  • A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families, 2020, PubMed
  • Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?, 2023, Schizophrenia Research
  • Clozapine and the risk of haematological malignancies, 2022, The Lancet Psychiatry
  • Desmopressine is and remains the drug of first choice for clozapine-induced nocturnal enuresis or urinary incontinence, 2023, CNS Spectrums
  • Replication Data for Crisis Signaling: How Italy's Coronavirus Lockdown Affected Incumbent Support in Other European Countries, 2020, Harvard Dataverse

Egbert Bakker has collaborated frequently with several co-authors, including:

  • Dan Cohen
  • Peter F.J. Schulte
  • Selene Veerman
  • Jan Bogers
  • Amy Jongkind

In recognition of their contributions to science, Egbert Bakker was awarded membership in the Royal Netherlands Academy of Arts and Sciences in 1999.

Best Publications

  • EAA/EMQN best practice guidelines for molecular diagnosis of y‐chromosomal microdeletions. State of the art 2004

    M. Simoni;E. Bakker;C. Krausz

  • AMYLOID-BETA PROTEIN-PRECURSOR GENE AND HEREDITARY CEREBRAL-HEMORRHAGE WITH AMYLOIDOSIS (DUTCH)

    C. Van Broeckhoven;J. Haan;E. Bakker;J. A. Hardy

  • Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.

    J. T. Den Dunnen;P. M. Grootscholten;E. Bakker;L. A. J. Blonden

  • Guidelines for diagnostic next-generation sequencing.

    Gert Matthijs;Erika Souche;Mariëlle Alders;Anniek Corveleyn

  • BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

    A. Petrij-Bosch;T. Peelen;M. Van Vliet;R. Van Eijk

  • Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.

    JT Wijnen;Hfa Vasen;PM Khan;AH Zwinderman

  • Estimating Y Chromosome Specific Microsatellite Mutation Frequencies using Deep Rooting Pedigrees

    E Heyer;J Puymirat;P Dieltjes;E Bakker

  • Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions

    M Simoni;E Bakker;M C Eurlings;Gert Matthijs

  • Population-based incidence and prevalence of facioscapulohumeral dystrophy.

    J.C.W. Deenen;H. Arnts;S.M. van der Maarel;G.W. Padberg

  • Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs.

    E Bakker;N Goor;K Wrogemann;L.M Kunkel

  • Analysis of Molecular Variance (Amova) of Y-Chromosome-Specific Microsatellites in Two Closely Related Human Populations

    L. Roewer;M. Kayser;P. Dieltjes;M. Nagy

  • Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study

    E M Hoogerwaard;E Bakker;P F Ippel;J C Oosterwijk

  • Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents

    Carla Rosenberg;Carla Rosenberg;J. Knijnenburg;E. Bakker;A. M. Vianna-Morgante

  • EAA/EMQN BEST PRACTICE GUIDELINES FOR MOLECULAR DIAGNOSIS OF Y CHROMOSOMAL MICRODELETIONS

    M Simoni;E Bakker

  • An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations.

    Manfred Kayser;Michael Krawczak;Laurent Georges Louis Excoffier;Patrick Dieltjes

  • Cerebral microbleeds in CADASIL.

    S. A. J. Lesnik Oberstein;R. van den Boom;M. A. van Buchem;H. C. van Houwelingen

  • Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

    E. Bakker;H. Veenema;J. T. Den Dunnen;C. Van Broeckhoven

  • Mutations in the EXT1 and EXT2 Genes in Hereditary Multiple Exostoses

    W. Wuyts;W. van Hul;K. de Boulle;J.J. Hendrickx

  • Duchenne muscular dystrophy: high frequency of deletions

    R. J. Bartlett;M. A. Pericak-Vance;J. Koh;L. H. Yamaoka

  • BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients (vol 17, pg 341, 1997)

    A. Petrij-Bosch;T. Peelen;M. van Vliet;R. van Eijk

Frequent Co-Authors

Peter L. Pearson
Peter L. Pearson Universidade de São Paulo
Martijn H. Breuning
Martijn H. Breuning Leiden University Medical Center
Rune R. Frants
Rune R. Frants Leiden University
Peter Devilee
Peter Devilee Leiden University Medical Center
Johan T. den Dunnen
Johan T. den Dunnen Leiden University Medical Center
George W. Padberg
George W. Padberg Radboud University
Hans Scheffer
Hans Scheffer Radboud University
Cisca Wijmenga
Cisca Wijmenga University Medical Center Groningen
Mayana Zatz
Mayana Zatz Universidade de São Paulo
Mariz Vainzof
Mariz Vainzof Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics in the USA can open doors to a range of related online degrees and diverse career pathways in healthcare and science. For students considering fields adjacent to genetics, several flexible options exist for both entry-level and advanced study.

Nursing remains a popular route for those keen on patient care and biomedical sciences. There are nursing programs without teas exams required, making the admission process less daunting for aspiring nurses. If you’re looking to join the workforce quickly, a 6 months lpn program offers a fast-track entry to healthcare.

For those ready to advance their careers or manage healthcare organizations, consider an affordable online master's in healthcare administration. Meanwhile, if an academic or leadership role in nursing is of interest, online phd nursing programs provide a pathway to high-level positions and research opportunities.

Whether starting your journey or moving forward in your profession, these flexible degree options create multiple entry and advancement points in the rapidly evolving healthcare and biomedical fields.

Best Scientists Citing Egbert Bakker

Trending Scientists

Recently Published Articles